Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.22.2
Stockholders' Equity (Details) - Equity Option [Member] - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options Outstanding, Beginning 420,000  
Weighted Average Exercise Price Outstanding, Beginning $ 5.82  
Options Outstanding Beginning 8 years 6 months 21 days  
Aggregate intrinsic value options outstanding $ 2,354,100
Number of Options Granted 0  
Weighted Average Exercise Price Granted $ 0  
Number of Options Exercised 0  
Weighted Average Exercise Price Exercised $ 0  
Number of Options Forfeited 0  
Weighted Average Exercise Price Forfeited $ 0  
Number of Options Outstanding, Ending 420,000 420,000
Weighted Average Exercise Price Outstanding, Ending $ 5.82 $ 5.82
Options Outstanding, Ending 8 years 6 months 21 days  
Number of Options Vested 367,787 315,288
Weighted Average Exercise Price Vested $ 5.38  
Options Vested 8 years 4 months 6 days  
Aggregate intrinsic value options vested $ 2,220,435  
Number of Options Exercisable, Ending 367,787  
Weighted Average Exercise Price Exercisable, Ending $ 5.38  
Options Exercisable 8 years 4 months 6 days  
Aggregate intrinsic value options exercisable $ 2,220,435